Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

MedImmune reports clinical data on asthma candidates MEDI-563 and MEDI-528

Oct. 5, 2010

Phase II trial of IMA-901 shows benefit of cyclophosphamide pretreatment

Oct. 4, 2010

NNC-126-0083 is well tolerated in adults and children with growth hormone deficiency

Oct. 4, 2010

Phase I investigation of CombiHIVvac HIV vaccine begins

Oct. 4, 2010

EP-017796 is active against drug-resistant bacteria

Oct. 4, 2010

Cationic peptide NP-339 is active against Candida species

Oct. 4, 2010

CMX-001 is not nephrotoxic in patients with viral infections

Oct. 4, 2010

Chitosan-GP is efficacious in ongoing trial in patients with articular cartilage lesions

Oct. 1, 2010

SAR-707 reveals limitations of acyl-CoA desaturase inhibition in metabolic disorders

Oct. 1, 2010

TransVax reduces cytomegalovirus viremia in phase II trial

Oct. 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...